Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 26

Trial Status

Other6

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT00000326Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
Heroin DependenceOpioid-Related Disorders
Principalinvestigator
NCT00000327Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
Heroin DependenceOpioid-Related Disorders
Principalinvestigator
NCT00000328Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
Heroin DependenceOpioid-Related Disorders
Principalinvestigator
NCT00000329Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
Heroin DependenceOpioid-Related Disorders
Principalinvestigator
NCT00000330Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
Heroin DependenceOpioid-Related Disorders
Principalinvestigator
NCT00000331Phase 2Withdrawn
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Heroin DependenceOpioid-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Colorado, Denver

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Jazmin Camchong, PhD

University of Minnesota

Moderately Similar
6 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Mark Greenwald, PhD

Wayne State University

Moderately Similar
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Moderately Similar
8 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Dependence

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

John Rotrosen, M.D.

New York MDRU

Moderately Similar
6 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Herbert Kleber, M.D.

New York State Psychiatric Institute

Moderately Similar
9 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Charles O'Brien, M.D., Ph.D.

PDVAMC Treatment Research Center

Related
7 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Elizabeth Ralevski, Ph.D.

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Robert P Schwartz, M.D.

Friends Research Institute, Inc.

Related
6 trials

Shared therapeutic areas:

Opioid-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Jeffrey L Schnipper, MD, MPH

Brigham and Women's Hospital

Related
8 trials

Shared therapeutic areas:

Opioid-Related Disorders
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00000326Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Heroin DependenceOpioid-Related Disorders
Withdrawn
NCT00000327Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2

Heroin DependenceOpioid-Related Disorders
Withdrawn
NCT00000328Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3

Heroin DependenceOpioid-Related Disorders
Withdrawn
NCT00000329Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

Heroin DependenceOpioid-Related Disorders
Withdrawn
NCT00000330Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

Heroin DependenceOpioid-Related Disorders
Withdrawn
NCT00000331Phase 2PrincipalInvestigator

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6

Heroin DependenceOpioid-Related Disorders
Withdrawn

All 6 trials loaded